Skip to Main Content

Paper Details

External validation of a prognostic model predicting overall survival in metastatic castrate-resistant prostate cancer patients treated with abiraterone.
Eur Urol
22
2014
Author NameAffiliation
Joaquin MateoThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Zafeiris ZafeiriouThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Roberta FerraldeschiThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Gerhardt AttardThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
Johann S de BonoThe Institute of Cancer Research and the Royal Marsden NHS Foundation Trust
  • 1 - 5

Datasets

Release 1.2